Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Lymphoma, B-Cell × Valproic Acid × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Lymphoma, B-Cell 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hematuria 1

Interventions

Rituximab 2 venetoclax 1 tafasitamab 1 pembrolizumab 1 glofitamab 1 fludarabine 1 avelumab 1 Valproic Acid 1 Melphalan 1 Ifosfamide 1 Gemcitabine 1 Etoposide 1 Dexamethasone 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02144623 2017-03-03

PREVAIL

Lund University Hospital

Phase EARLY_PHASE1 Completed

LymphoidOther hematologic neoplasm

Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡